Clinical Scorecard: Digital Twins for Rare Diseases

At a Glance

Key Highlights

• Digital twins can help overcome recruitment limitations in rare disease studies.
• Mechanism-based evidence is gaining acceptance in regulatory pathways.
• Digital patient profiles provide detailed insights into patient populations.
• Predictive analysis can improve site selection for clinical trials.
• Quality of data is critical for the trustworthiness of digital twin insights.

Guideline-Based Recommendations

Diagnosis

• Utilize comprehensive diagnostic data including histopathology, genomic sequencing, and laboratory tests.

Management

• Adopt digital twins and patient profiles to inform clinical development and trial design.

Monitoring & Follow-up

• Engage with regulatory agencies to ensure transparency and reproducibility of digital twin models.

Risks

• Limited historical data may increase the risk of protocol issues in rare disease studies.

Patient & Prescribing Data

Patients with rare diseases, often with fewer than one per 100,000 prevalence.

Digital twins can facilitate personalized treatment approaches and reduce diagnostic delays.

Clinical Best Practices

• Embrace digital twin technology to stay current in rare disease diagnostics.
• Contextualize patient data to enhance understanding of rare disease populations.
• Utilize real-world data to build accurate digital twins reflecting patient populations.

Related Resources & Content

• Orphanet